Related Experiment Video

Updated: Jun 10, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Flupirtine may stop the progressive course of subacute sclerosing panencephalitis

Burak Tatli1, Bariş Ekici, Meral Ozmen

  • 1Istanbul Medical Faculty, Pediatric Neurology Department, Istanbul, Turkey.

Medical Hypotheses
|August 13, 2010
PubMed

Insights

Subacute sclerosing panencephalitis (SSPE) is a progressive neurological disease. Combining the anti-apoptotic drug flupirtine with antiviral therapy may halt SSPE progression.

Area of Science:

  • Neurology
  • Virology
  • Cell Biology

Background:

  • Subacute sclerosing panencephalitis (SSPE) is a progressive and devastating neurological disease.
  • Apoptotic cell death and measles virus infection are key pathogenic mechanisms in SSPE.
  • Early stages of SSPE are characterized by frontotemporal cortex volume reduction.

Purpose of the Study:

  • To investigate the potential of flupirtine, an anti-apoptotic agent, in treating SSPE.
  • To evaluate the efficacy of combining flupirtine with antiviral therapies for SSPE.

Main Methods:

  • Review of existing literature on SSPE pathogenesis and treatment options.
  • Analysis of flupirtine's mechanism of action and its application in other neurodegenerative diseases.
  • Hypothesizing a combination therapy approach for SSPE.

Main Results:

  • Current antiviral therapies like isoprinosine and alpha-interferon show limited success in treating SSPE.
  • Flupirtine has demonstrated limited efficacy in other apoptosis-related diseases such as Alzheimer's and prion diseases.
  • No definitive results from clinical trials on flupirtine for SSPE are available.

Conclusions:

  • Flupirtine's anti-apoptotic properties suggest a potential therapeutic role in SSPE.
  • Combination therapy with flupirtine and antivirals may offer a novel strategy to halt SSPE progression.
  • Further research and clinical trials are warranted to validate this therapeutic hypothesis.

More Related Videos

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Related Concept Videos

Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...